Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Hydrogen Storage Collaboration Between Sigma-Aldrich and Ilika Technologies to Scale-up and Commercialize Boron Hydride Materials

Published: Monday, July 25, 2011
Last Updated: Monday, July 25, 2011
Bookmark and Share
Materials show promise as high energy, low pressure hydrogen source.

Aldrich Materials Science, a strategic technology initiative of Sigma-Aldrich Corporation has announced that it has signed an agreement to collaborate on the scale-up and commercialization of next generation hydrogen-storage materials with Ilika plc, an advanced cleantech materials discovery company.

Both companies believe this enterprise will become a vital component of the energy industry's efforts to develop consumer-friendly hydrogen storage materials for fuel cell and clean combustion technology.

Hydrogen represents an attractive carrier of energy as its combustion or direct conversion to electricity via a fuel cell does not lead to the emission of carbon dioxide.

In addition, hydrogen can be used as an alternative energy carrier to battery technology since the energy density of hydrogen can be substantially higher than that of batteries.

The main criteria for hydrogen storage for transport purposes, as outlined by the US Freedom Car Initiative (http://www.afdc.energy.gov/afdc/pdfs/freedomcar_plan.pdf), are to supply enough hydrogen to enable a driving range of approximately 500 km, to charge and recharge at near room temperature and to provide hydrogen at rates fast enough for vehicular operation - from cars to trains.

Current prototype applications use very high pressure compressed hydrogen or cryogenically cooled liquid hydrogen. These methods consume a significant percentage of the energy content in their compression and conversion and both raise safety concerns.

Ilika's storage solution is a solid metal hydride, which exists as a powder stored in a cylinder at moderate pressure and stable at room temperature. When warmed to moderate temperatures, hydrogen is released for use as fuel.

To be economically viable, the target weight percentage of hydrogen stored in such a material has been set at 6% by the US Department of Energy. Current commercially available hydride materials can achieve up to 2.3 weight % of hydrogen.

The hydride materials being verified and scaled-up by Aldrich Materials Science can potentially store up to 10 weight % of hydrogen, reversibly.

Commenting on the collaboration, Ilika's CEO, Graeme Purdy, said: "This agreement is a great example of how Ilika, together with our partners, develops innovative materials that solve complex industrial challenges and shares in the commercial upside that these technological advances make possible. Sigma-Aldrich® is a world leader with renowned capability in the field of materials science. Through its Aldrich Materials Science initiative, Sigma-Aldrich possesses state-of-the-art integrated capabilities in hydrogen storage materials for fuel cell technology, including material development (mechanochemistry), manufacturing, application and evaluation, and have agreed to enter into a collaboration to scale-up Ilika's metal-hydride materials. In particular, their mechanochemistry know-how and processing is a proven tool for the preparation of novel materials. We are very pleased to be working with them."

R&D Manager for Aldrich Materials Science, Viktor Balema, added: "We have been very impressed by Ilika's unique high-throughput discovery capabilities, which are very complementary to our scale-up facilities. The collaboration, done as part of our custom research services, creates the unique opportunity to rapidly move from discovery to first commercialization, with the potential of making innovative energy storage materials available to end users in a short period of time. Through collaborative custom research projects, we aim to enable materials innovation in the alternative energy, electronics and biomedical markets."


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More Than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

SAFC Completes Manufacturing Expansion in St. Louis
Expansion to support commercial-scale antibody drug conjugate (ADC) manufacturing.
Saturday, May 16, 2015
SAFC Expands Carlsbad, Calif. Facility
Expansion to support commercial-scale gene therapy production, testing and filling.
Saturday, May 16, 2015
Sigma-Aldrich Expands in Singapore
New State-of-the-Art Technical Center, cGMP Distribution Center and Headquarters enhances ability to support customers in the region.
Monday, April 20, 2015
Sigma-Aldrich & Roche Enter Exclusive Distribution Agreement
Provides researchers with global access to Roche biochemical reagents product portfolio.
Thursday, March 19, 2015
Sigma and Czech Center for Phenogenomics Collaborate
Sigma-Aldrich® and the Institute of Molecular Genetics, Czech Center for Phenogenomics, establish CRISPR core lab collaboration.
Friday, January 30, 2015
SAFC’s Dry Powder Media Manufacturing Facility in Irvine, Scotland
Officially opens following extensive validation process.
Friday, January 23, 2015
Sigma-Aldrich Licenses Foundational CRISPR Patents from Broad Institute
Company is able to make, use and distribute the advanced gene editing tools for numerous research applications.
Tuesday, December 09, 2014
Sigma-Aldrich to Restructure Business into Three New Units
Sigma-Aldrich has provided the first details of a major restructuring that will align its organisation into three customer and market-focused business units.
Thursday, November 22, 2012
SAGE® Labs, Ekam Imaging, Inc. Partner on Preclinical Imaging Assays
Companies to develop a suite of preclinical services based on the advanced translational power of genetically engineered rat models from SAGE Labs and Ekam's expertise in functional magnetic resonance imaging (fMRI) technology.
Friday, October 19, 2012
Sigma-Aldrich to Acquire BioReliance
Sigma-Aldrich Corporation has signed an agreement to acquire BioReliance Holdings, Inc. from Avista Capital Partners for $350 million in cash.
Tuesday, January 10, 2012
Biotech firm inks deal with Sigma-Aldrich
Henrietta-based biotechnology company Diffinity Genomics Inc. has inked a non-exclusive global distribution deal with Sigma-Aldrich Co. LLC, the local company said.
Wednesday, November 30, 2011
Domainex Collaborates with Sigma-Aldrich to Advance the Study of Epigenetic Proteins Involved in Cancer and Stem Cell Biology
Domainex Ltd., have announced a collaboration with Sigma-Aldrich that will provide essential tools, including biochemical assays and monoclonal antibodies, for the study of proteins involved in the rapidly developing field of epigenetics.
Monday, November 15, 2010
Sigma® Life Science to Supply Oligonucleotides to Research Councils UK
A three-year contract with RCUK Shared Services Centre Limited to be a preferred supplier for synthetic oligonucleotides.
Monday, September 20, 2010
Sigma-Aldrich® Receives National Institutes of Health Funding for Cardiovascular Disease Research
Sigma® Life Science to analyze plasma samples from FHS in researching novel biomarkers for cardiovascular disease.
Monday, August 09, 2010
Sigma-Aldrich to Host Molecular Self-Assembly Webcast
November 17 Webcast Features MSA Scientific Leaders Professor Paul Weiss and Professor Milan Mrksich
Wednesday, November 11, 2009
Scientific News
Microdroplet Reactors Mimic Living Systems
Researchers use microdroplets to study non-equilibrium reactions like those in living organisms.
NIH Researchers Identify Striking Genomic Signature for Cancer
Institute has identified striking signature shared by five types of cancer.
CRI Develops Innovative Approach for Identifying Lung Cancer
Institute has developed innovative approach for identifying processes that fuel tumor growth in lung cancer patients.
Envigo Rat Models Proven to be Susceptible to Intra-Vaginal HSV-2 Infection and Protectable
Scientific findings establish the effectiveness of new approach to investigate the protective effects of vaccine candidates and anti-viral microbodies and to study asymptomatic primary genital HSV-2 infection.
What do Banana Peels and Human Skin Have in Common?
Human skin and banana peels have something in common: they produce the same enzyme when attacked. By studying fruit, researchers have come up with an accurate method for diagnosing the stages of this form of skin cancer.
The Spice of Life
Scientists discover important genetic source of human diversity.
Cytoskeleton Crew
Findings confirm sugar's role in helping cancers survive by changing cellular architecture.
The Power of Three
Overlooked portion of cell “death receptor” critical in some cancers, autoimmune diseases.
Drug that Activates Innate Immune System Identified
Researchers from the institute have identified a drug, which is straightforward to synthesize and to couple to antigens that induce an immune response and may prove useful in the generation of vaccines.
Removing Race from Human Genetic Research
A group of scientists are urging their colleagues to take a step forward and stop using racial categories when researching and studying human genetics.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!